Accessibility Menu
 
4d Pharma Plc logo

4d Pharma Plc

(LSE) DDDD

Current PriceN/A
Market CapN/A
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A

4d Pharma Plc Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$158.25K

Net Income (TTM)

$23.97M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

DDDD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 4d Pharma Plc

Industry

Pharmaceuticals

CEO

Duncan Peyton

Headquarters

Leeds, LS1 2JZ, GB

DDDD Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-44%

Net Income Margin

-44%

Return on Equity

-1%

Return on Capital

-60%

Return on Assets

-54%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$718.00K

Operating Income

$31.38M

EBITDA

$30.03M

Operating Cash Flow

$37.92M

Capital Expenditure

$279.00K

Free Cash Flow

$38.20M

Cash & ST Invst.

$20.97M

Total Debt

$12.80M

4d Pharma Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2019YOY CHG

Revenue

$52.75K

N/A

Gross Profit

$52.75K

N/A

Gross Margin

100.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

106

N/A

Net Income

$6.02M

-1.6%

EBITDA

$6.91M

-2.8%

Quarterly Fundamentals

Name
Q2 2019YOY CHG

Net Cash

$8.17M

+199.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

-100.0%

Long Term Debt

$12.70M

+1117.3%

Short Term Debt

$108.00K

+58.8%

Return on Assets

-54.32%

N/A

Return on Invested Capital

-60.14%

N/A

Free Cash Flow

$5.54M

+5.7%

Operating Cash Flow

$5.39M

+6.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
C4XD.LC4X Discovery Holdings plc
$12.00+27.32%
MTPH.LMidatech Pharma plc
$18.00+1794.74%
OKYO.LOKYO Pharma Limited
$1.40-24.32%
SNG.LSynairgen plc
$0.95+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NKENike
$44.63-0.16%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%

Questions About DDDD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.